| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0190-9622(96)90017-1 |
| P698 | PubMed publication ID | 8632077 |
| P2093 | author name string | Zitelli JA | |
| Buzzell RA | |||
| P2860 | cites work | Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma | Q24540048 |
| Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients | Q30466404 | ||
| Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma | Q71758295 | ||
| Prognostic parameters in recurrent malignant melanoma | Q71761060 | ||
| Surgery in recurrent malignant melanoma | Q71821373 | ||
| How wide and deep is wide and deep enough? A critique of surgical practice in excisions of primary cutaneous malignant melanoma | Q71826900 | ||
| Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis | Q72559262 | ||
| Surgical treatment of distant metastatic melanoma. Indications and results | Q93593032 | ||
| Treatment of regional nodes | Q35532114 | ||
| Data on first recurrence after treatment for malignant melanoma in a large patient population. | Q36774613 | ||
| Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic | Q37521168 | ||
| Loco-regional primary and recurrent melanoma: III. Update of natural history and non-systemic treatments (1980-1987). | Q39513142 | ||
| Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients | Q39616273 | ||
| The role of elective lymph node dissection in melanoma: rationale, results, and controversies | Q39625646 | ||
| Prognosis for recurrent stage I malignant melanoma | Q39784979 | ||
| The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma | Q39856615 | ||
| Prognostic value of lymph node dissection in malignant melanoma | Q40361763 | ||
| Prognostic factors in metastatic melanoma | Q40717782 | ||
| Relationship between disease-free interval and survival in patients with recurrent melanoma | Q41101757 | ||
| Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes | Q41457969 | ||
| Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience | Q41459531 | ||
| Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma | Q41523597 | ||
| Malignant melanoma: significance of disease-free interval | Q41646721 | ||
| Clinical Evaluation of Cutaneous Malignant Melanoma with Histologically Involved Lymph Node Metastases | Q43669407 | ||
| Late relapse from cutaneous stage I malignant melanoma | Q43797803 | ||
| Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients | Q44190417 | ||
| Cutaneous melanoma: prognosis and treatment results worldwide | Q44432993 | ||
| Biostatistical basis of elective node dissection for malignant melanoma | Q44714324 | ||
| Late recurrence of stage I malignant melanoma | Q46799285 | ||
| The natural history of resectable metastatic melanoma (Stage IVA melanoma). | Q48883753 | ||
| Late recurrence of malignant melanoma. Analysis of 168 patients. | Q50554786 | ||
| Inefficacy of immediate node dissection in stage 1 melanoma of the limbs | Q50986397 | ||
| The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide. | Q53390864 | ||
| A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results | Q67316111 | ||
| A case-control study of late recurrence of malignant melanoma | Q67586743 | ||
| The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma | Q67720569 | ||
| Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients | Q68252683 | ||
| Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma | Q68273630 | ||
| Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience | Q68406098 | ||
| Elective regional lymph node dissection in malignant melanoma | Q68430381 | ||
| Axillary dissection in melanoma. Prognostic variables in node-positive patients | Q68864789 | ||
| Early metastatic patterns and survival in malignant melanoma | Q68969395 | ||
| Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma | Q69634167 | ||
| Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases | Q69716711 | ||
| Effect of surgical treatment on stage IV melanoma | Q69774688 | ||
| A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia | Q70535936 | ||
| The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma | Q70700824 | ||
| A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) | Q70717837 | ||
| Surgical management of regional lymph nodes in cutaneous melanoma | Q70730854 | ||
| Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes | Q70755933 | ||
| A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III) | Q71186808 | ||
| Prognosis of skin melanoma with regional node metastases (stage II) | Q71331841 | ||
| Prognostic significance of lymph node dissection in the treatment of malignant melanoma | Q71539972 | ||
| LDH and melanoma | Q71651850 | ||
| Optimal resection margin for cutaneous malignant melanoma | Q71729362 | ||
| P433 | issue | 5 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metastatic melanoma | Q18975855 |
| P304 | page(s) | 798-803 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Favorable prognostic factors in recurrent and metastatic melanoma | |
| P478 | volume | 34 |
| Q43927253 | Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot study |
| Q41467163 | Adjuvant therapy for cutaneous malignant melanoma |
| Q74525284 | Factors affecting survival following local, regional, or distant recurrence from localized melanoma |
| Q33706946 | Immune and gene therapy for melanoma, and the immunobiology of melanoma |
| Q39251469 | Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype |
| Q77797513 | Malignant melanoma |
| Q34794495 | Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour |
| Q77621113 | Metastatic malignant melanoma presenting as malabsorption |
| Q79276593 | Metastatic melanoma of the skin: Surgical treatment |
| Q78066441 | Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma |
| Q45775040 | Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma |
| Q37952237 | New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB). |
| Q33760888 | Photosensitivity diseases: cutaneous lupus erythematosus |
| Q35856660 | Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma |
| Q51400745 | Protein-Losing Enteropathy in a Post-partum Female Secondary to Metastatic Melanoma of the Gut: Report of a Case. |
| Q77934757 | Skin cancer of the head and neck |
| Q33689227 | Treatment of malignant melanoma |
Search more.